MYL3

MYL3

Target · Myosin light chain

MYL3 Myosin light chain 3 · ventricular/slow skeletal alkali light chain

MYL3 (myosin light chain 3) is an alkali light chain of myosin, described in the literature as both the ventricular isoform and the slow skeletal muscle isoform. It is also known as CMH8, VLC1, MLC1V and MLC1SB. Browse Assay Genie's current range of MYL3 research reagents below, or read on for the biology behind the target.

Myosin light chainDoes not bind calciumLinked to cardiomyopathy
195 aa
Protein length
~22 kDa
Molecular weight
3p21.31
Gene locus
Myosin light chain
Protein family
Target information

What is MYL3 (myosin light chain 3)?

MYL3 is a light chain of myosin. UniProt describes it as a regulatory light chain of myosin that does not bind calcium. The NCBI Gene summary classes it as an alkali light chain, and the literature refers to it as both the ventricular isoform and the slow skeletal muscle isoform. Researchers studying cardiac and slow skeletal muscle myosin therefore often work with the MYL3 protein as a reference for this light chain class.

The MYL3 gene encodes myosin light chain 3. HGNC places it in the gene group of myosin light chains, class 1. The human gene has mouse and rat orthologs, both named Myl3, which allows comparative work in common model organisms. Detailed tissue expression and subcellular localisation are not annotated in the sources used here.

The aliases reflect the protein's history. HGNC lists the previous names as myosin, light polypeptide 3, alkali; ventricular, skeletal, slow, and myosin, light chain 3, alkali; ventricular, skeletal, slow. The symbols VLC1, MLC1V and MLC1SB echo the ventricular and slow skeletal descriptions, while CMH8 reflects the disease association. Mutations in MYL3 have been identified as a cause of mid-left ventricular chamber type hypertrophic cardiomyopathy, which makes the MYL3 gene a focus in cardiomyopathy research. Reagents such as an MYL3 antibody or MYL3 ELISA kit are commonly used to examine this light chain in muscle biology.

Hypertrophic cardiomyopathy research

Mutations in MYL3 have been identified as a cause of mid-left ventricular chamber type hypertrophic cardiomyopathy, making it a key gene in this disease.

Cardiac muscle biology

MYL3 is known as the ventricular isoform of the myosin alkali light chain, so it is relevant to studies of ventricular myosin.

Slow skeletal muscle studies

MYL3 is also described as the slow skeletal muscle isoform, linking it to research on slow-twitch muscle myosin composition.

Myosin regulation

MYL3 is a regulatory light chain of myosin that does not bind calcium, informing work on myosin light chain function.

Background

MYL3 frequently asked questions

What does MYL3 do?

MYL3 is a regulatory light chain of myosin, and UniProt notes that it does not bind calcium. NCBI Gene classes it as an alkali light chain, described in the literature as both the ventricular and the slow skeletal muscle isoform.

What other names does MYL3 go by?

MYL3 is also called CMH8, VLC1, MLC1V and MLC1SB. Earlier HGNC names were myosin, light polypeptide 3, alkali; ventricular, skeletal, slow, and myosin, light chain 3, alkali; ventricular, skeletal, slow.

Is MYL3 linked to disease and conserved in rodents?

Yes. Mutations in MYL3 have been identified as a cause of mid-left ventricular chamber type hypertrophic cardiomyopathy. Mouse and rat both have a Myl3 ortholog; check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other myosin light chains and related myosin regulators with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P08590; product specifications from Assay Genie datasheets.

MYL3 Product listing